ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,084.19
0.82%
Dow Jones
44,148.56
-0.22%
US Dollar vs MXN
20.13375
0.02%
Brent Oil
73.72
0.37%
Bitcoin
100,946.95
-0.24%
Pepperstone
Advertisement
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Guilford Pharmaceuticals (MM) (GLFD)

  7. Guilford Pharmaceuticals (MM) (GLFD) Noticias

GLFD

Guilford (GLFD)

Guilford Pharmaceuticals (MM)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:GLFD
FechaHoraFuenteTítuloSímboloCompañía
29/09/200517:27PR Newswire (US)Guilford Pharmaceuticals Stockholders Vote to Approve MGI PHARMA MergerNASDAQ:GLFDGuilford Pharmaceuticals (MM)
01/09/200506:00Business WireMGI PHARMA and Guilford Pharmaceuticals Announce Expiration of the Hart-Scott-Rodino Waiting PeriodNASDAQ:GLFDGuilford Pharmaceuticals (MM)
08/08/200509:11PR Newswire (US)Guilford Pharmaceuticals Reports 2005 Second Quarter ResultsNASDAQ:GLFDGuilford Pharmaceuticals (MM)
08/08/200507:45PR Newswire (US)Guilford Pharmaceuticals to Announce Second Quarter 2005 Financial Results on Monday, August 8, 2005NASDAQ:GLFDGuilford Pharmaceuticals (MM)
24/05/200514:44PR Newswire (US)Guilford Pharmaceuticals Implements Strategic Reorganization to Align Resources With Corporate StrategyNASDAQ:GLFDGuilford Pharmaceuticals (MM)
18/05/200514:00PR Newswire (US)Guilford Pharmaceuticals Presents New NAALADase Inhibitor Data in Chemotherapy-Induced Neuropathy at ASCONASDAQ:GLFDGuilford Pharmaceuticals (MM)
17/05/200514:39PR Newswire (US)Guilford Pharmaceuticals Announces Promising Results at ASCO in Study of Newly Diagnosed High Grade Malignant GliomaNASDAQ:GLFDGuilford Pharmaceuticals (MM)
11/05/200510:01PR Newswire (US)AGGRASTAT(R) Injection Strategy Trial Data Published in JAMANASDAQ:GLFDGuilford Pharmaceuticals (MM)
09/05/200508:42PR Newswire (US)Guilford Pharmaceuticals Reports 2005 First Quarter ResultsNASDAQ:GLFDGuilford Pharmaceuticals (MM)
09/05/200507:45PR Newswire (US)Guilford Pharmaceuticals to Announce First Quarter 2005 Financial Results on Monday, May 9, 2005NASDAQ:GLFDGuilford Pharmaceuticals (MM)
21/04/200513:07PR Newswire (US)Guilford Pharmaceuticals Restarts AQUAVAN(R) Clinical Development ProgramNASDAQ:GLFDGuilford Pharmaceuticals (MM)
06/04/200507:45PR Newswire (US)Guilford Pharmaceuticals to Host Webcast Outlining New Corporate StrategyNASDAQ:GLFDGuilford Pharmaceuticals (MM)
24/03/200511:04PR Newswire (US)Guilford Pharmaceuticals Announces Phase III AQUAVAN(R) Trial Meets Primary EndpointNASDAQ:GLFDGuilford Pharmaceuticals (MM)
08/03/200510:03PR Newswire (US)Guilford Pharmaceuticals: AGGRASTAT(R) Injection Clinical Data Presented at American College of Cardiology Annual MeetingNASDAQ:GLFDGuilford Pharmaceuticals (MM)
01/03/200514:55PR Newswire (US)Guilford Pharmaceuticals Reports 2004 Year-End Financial ResultsNASDAQ:GLFDGuilford Pharmaceuticals (MM)
01/03/200506:45PR Newswire (US)Guilford Pharmaceuticals to Announce 2004 Year-End Financial Results on Tuesday, March 1, 2005NASDAQ:GLFDGuilford Pharmaceuticals (MM)
17/12/200416:30PR Newswire (US)Guilford Pharmaceuticals Completes Sale and Leaseback and Receives $19.4 Million in Net ProceedsNASDAQ:GLFDGuilford Pharmaceuticals (MM)
02/12/200407:45PR Newswire (US)Guilford Pharmaceuticals to Acquire ProQuest Pharmaceuticals; Guilford to Obtain Exclusive Worldwide Ownership of AQUAVAN(R) ProNASDAQ:GLFDGuilford Pharmaceuticals (MM)
22/11/200408:03PR Newswire (US)Guilford Pharmaceuticals Presents New GLIADEL(R) Wafer Data at the Society for Neuro-Oncology Annual MeetingNASDAQ:GLFDGuilford Pharmaceuticals (MM)
17/11/200416:30PR Newswire (US)Guilford Pharmaceuticals Announces Equity Compensation Arrangement With Dean J. Mitchell Pursuant to NASDAQ RulesNASDAQ:GLFDGuilford Pharmaceuticals (MM)
17/11/200407:01PR Newswire (US)Dean J. Mitchell Appointed President and Chief Executive Officer of Guilford PharmaceuticalsNASDAQ:GLFDGuilford Pharmaceuticals (MM)
12/11/200409:58PR Newswire (US)AGGRASTAT(R) Strategy Trial Data Presented At American Heart Association Annual MeetingNASDAQ:GLFDGuilford Pharmaceuticals (MM)
08/11/200411:11PR Newswire (US)Guilford Pharmaceuticals Reports 2004 Third Quarter ResultsNASDAQ:GLFDGuilford Pharmaceuticals (MM)
05/11/200407:30PR Newswire (US)Guilford Pharmaceuticals to Announce Third Quarter 2004 Financial Results on Monday, November 8, 2004NASDAQ:GLFDGuilford Pharmaceuticals (MM)
27/09/200409:33PR Newswire (US)Guilford Pharmaceuticals Announces Orphan Drug Designation for GLIADEL(R) Wafer; Market Exclusivity for GLIADEL(R) Extends UntilNASDAQ:GLFDGuilford Pharmaceuticals (MM)
22/09/200409:03PR Newswire (US)Guilford to Present at UBS Global Life Sciences ConferenceNASDAQ:GLFDGuilford Pharmaceuticals (MM)
20/09/200410:05PR Newswire (US)Guilford Pharmaceuticals Begins Phase III Clinical Trials of AQUAVAN(R) InjectionNASDAQ:GLFDGuilford Pharmaceuticals (MM)
17/09/200409:00PR Newswire (US)Guilford Pharmaceuticals Receives $6 Million For Rights to Polymer Drug Delivery PatentsNASDAQ:GLFDGuilford Pharmaceuticals (MM)
14/09/200412:00PR Newswire (US)Guilford Pharmaceuticals Receives European Marketing Authorization for Expanded Use of GLIADEL(R) WaferNASDAQ:GLFDGuilford Pharmaceuticals (MM)
01/09/200408:58PR Newswire (US)Guilford Pharmaceuticals Announces Craig R. Smith, M.D. Will Retire as Chairman, President and Chief Executive OfficerNASDAQ:GLFDGuilford Pharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:GLFD

Su Consulta Reciente

NYSE
AXP
American Express
NYSE
XOM
Exxon Mobil
CCOM
US30
US 30
FX
EURUSD
Euro vs US Dollar
USOTC
RHHBY
Roche (QX)
NASDAQ
AAPL
Apple
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
JPM
JP Morgan Chase
COIN
XRPUSD
Ripple
CCOM
SILVER
SILVER
FX
EURMXN
Euro vs MXN
COIN
AVAXUSD
Avalanche
COIN
ADAUSD
Cardano
COIN
BTCUSD
Bitcoin
COIN
SOLUSD
Solana
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados